Assessing AI for Detecting Lung Nodules and Cancer: Pre- and Post-Deployment Study (NCT06746324) | Clinical Trial Compass
WithdrawnNot Applicable
Assessing AI for Detecting Lung Nodules and Cancer: Pre- and Post-Deployment Study
Stopped: No IRB approval
0Started 2025-05-15
Plain-language summary
The study evaluates the impact of qXR-LN compared to standard radiologist-only interpretations before and after AI deployment. The goal is to compare how well lung nodules and cancers are detected in two time periods: before and after the implementation of the AI tool in routine clinical practice. The study aims to determine whether the AI system can help radiologists identify more actionable lung nodules and diagnose lung cancer earlier, ultimately improving patient outcomes.
No changes will be made to patients' standard care, and all treatment decisions will be based on the clinical judgment of physicians. The study includes patients over 35 years old who undergo chest X-rays for various medical reasons, excluding those with known lung cancer.
Who can participate
Age range
35 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age ≥35 years at the time of chest X-ray acquisition
* Chest X-ray must be obtained as part of routine care (e.g., ordered for respiratory complaints, screening, or other clinical indications)
* Chest X-ray performed using CR/DR/DX imaging modality
* Examination described as "Chest"
* View: PA or AP
* Patient positioned as Erect or Supine
* Image available in valid DICOM format with proper DICOM prefix values (including "DICM" in the header)
Exclusion Criteria:
* Patients aged \<35 years at the time of chest X-ray
* Patients with known lung cancer at the time of chest X-ray acquisition
* Lateral views or any imaging modality other than CR/DR/DX
* Imaging or anatomy not specified as Chest (e.g., different body parts or modalities)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Difference in Nodule Detection Rate Between Pre- and Post-Deployment Cohorts
Timeframe: Through study completion, approximately 12 months.